Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
27.93
-1.02 (-3.52%)
Aug 14, 2026, 1:00 PM EDT - Market open
Pelthos Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Pelthos Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $53.14. The average 1-year stock price forecast is 90.26% higher than the current stock price, while the lowest is $45 (+61.12%) and the highest is $64 (+129.14%).
Price Target: $53.14 (+90.26%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pelthos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $66 → $64 | Buy | Reiterates | $66 → $64 | +129.14% | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +114.82% | Aug 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $48 | Buy | Reiterates | $48 | +71.86% | Aug 14, 2026 |
| Lake Street | Lake Street | Buy Maintains $50 | Buy | Maintains | $50 | +79.02% | Aug 14, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $75 → $45 | Buy | Maintains | $75 → $45 | +61.12% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
63.92M
from 16.80M
Increased by 280.56%
Revenue Next Year
121.18M
from 63.92M
Increased by 89.59%
EPS This Year
-10.66
from -13.29
EPS Next Year
-2.13
from -10.66
EPS and Forward PE are based on non-GAAP adjusted numbers.